Breast Cancer Therapeutics Market size to exceed $30,637.7 Mn by 2025
Published Date: March 6, 2019 Authors: Sumant Ugalmugle, Rupali Swain
Breast Cancer Therapeutics Market size is set to exceed USD 30,637.7 million by 2025; according to a new research study published by Global Market Insights, Inc.
Rising prevalence of breast cancer launch of numerous diagnostic and screening programs globally and favorable insurance and reimbursement policies will serve as high influential factors for the global market growth.
Advancement in technologies for cancer biology, increasing research and development for introduction of novel drugs to treat the disease will stimulate industry growth over the coming years. Rising adoption of minimally invasive cancer therapy methods should improve patient compliance.
Get more details on this report - Request Free Sample PDF
Moreover, increasing awareness towards disease prevention, early screening and diagnosis will further propel the industry size. However, prohibitive cost associated with breast cancer therapeutics may restrain its adoption in emerging economies. Compliance to therapy may reduce due to high maintenance treatment price.
Browse key industry insights spread across 150 pages with 160 market data tables & 12 figures & charts from the report, “Breast Cancer Therapeutics Market Size By Product (Hormone Drugs, Chemotherapy Drugs, Targeted Drug Therapy), By Distribution Channel (Hospitals, Ambulatory Surgical Centers, Clinics, Ecommerce, Retail Pharmacies), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents:
Targeted drug therapy market is estimated to witness significant growth at 10.3% over the forecast period owing to factors such as their structure that is deliberately designed to interact with their target and search for specific molecular targets that are associated with cancer. Growing focus of much anticancer drug development on targeted therapies will drive the augmented demand for these products.
Hormone drugs market was valued around USD 3,292.4 million in the year 2018. Features such as affecting the activities of tissues and cells at numerous sites in the body, frequently reaching their targets through bloodstream will drive the segment growth. Moreover, slowing or stopping the development of hormone-sensitive tumors by interfering with effects of hormones on breast cancer cells or by blocking the body’s capability to produce hormones will offer significant segment growth opportunity.
Distribution of breast cancer therapeutics through retail pharmacies is estimated grow at 9.7% over the projection period. The distribution of breast cancer therapeutics through retail pharmacies has become the most popular medium. In 2018, retail pharmacies held the largest market share and will grow at considerable rate over the forecast timeframe owing to increased number of pharmacies in both developed and developing regions.
U.S. market accounted for largest business share in 2018 and is anticipated to grow substantially at 9.1% over the forecast period. Increases access to breast cancer screening, diagnosis and treatment services will be the chief growth rendering factor. Moreover, increasing adoption of therapy drug by patients will fuel regional business growth. Rising incidence of disease due to increasing exposure to factors such as use of hormone replacement therapy (HRT), lifestyle related factors such as alcohol consumption, obesity and alteration in family size which stimulates the usage rate of therapeutics over the forecast period will propel the industry growth.
Japan dominated the Asia Pacific breast cancer therapeutics market and was valued around USD 1,284.8 million in the year 2018. The high market share is attributed to increase in awareness programs to spread alertness regarding breast cancer screening, robust economic growth and rising disposable income.
Brazil breast cancer therapeutics market is projected to grow at a 10.2% CAGR over the forecast period. Increased life expectancy among individuals and healthcare facility development are the chief features driving breast cancer therapeutics market growth in the country.
Some of the companies operating in breast cancer therapeutics market are Roche Diagnostics, Pfizer, AstraZeneca, Novartis, Sanofi, Eisai, and Eli Lily. New product launches, strong product pipeline, geographical expansion, mergers and acquisition will mainly boost the business. Chief industry players will endeavor to strengthen their place in this competitive market by implementation these strategies.
Breast cancer therapeutics market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2014 to 2025, for the following segments:
Breast Cancer Therapeutics Market by Product
- Hormone Drugs
- Chemotherapy Drugs
- Targeted Drug Therapy
Breast Cancer Therapeutics Market by Distribution Channel
- Ambulatory Surgical Centers
- Retail Pharmacies
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- South Africa
- Saudi Arabia